Siemens Fonds Invest’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$785K Hold
3,633
0.04% 290
2026
Q1
$666K Buy
3,633
+112
+3% +$20.6K 0.04% 293
2025
Q4
$621K Hold
3,521
0.03% 299
2025
Q3
$493K Sell
3,521
-19
-0.5% -$2.57K 0.03% 317
2025
Q2
$445K Buy
3,540
+332
+10% +$41.4K 0.03% 325
2025
Q1
$439K Sell
3,208
-1,212
-27% -$173K 0.03% 299
2024
Q4
$664K Sell
4,420
-1,100
-20% -$186K 0.04% 258
2024
Q3
$816K Sell
5,520
-874
-14% -$183K 0.06% 215
2024
Q2
$1.48M Hold
6,394
0.11% 191
2024
Q1
$1.38M Sell
6,394
-72
-1% -$16.9K 0.11% 198
2023
Q4
$1.67M Buy
6,466
+981
+18% +$241K 0.14% 194
2023
Q3
$1.41M Sell
5,485
-1,242
-18% -$332K 0.14% 165
2023
Q2
$1.91M Hold
6,727
0.19% 137
2023
Q1
$1.87M Sell
6,727
-18
-0.3% -$4.98K 0.2% 138
2022
Q4
$1.87M Sell
6,745
-371
-5% -$105K 0.19% 135
2022
Q3
$1.9M Hold
7,116
0.22% 125
2022
Q2
$1.45M Sell
7,116
-58
-0.8% -$11.9K 0.15% 155
2022
Q1
$1.51M Hold
7,174
0.12% 160
2021
Q4
$1.72M Buy
7,174
+472
+7% +$121K 0.11% 163
2021
Q3
$1.9M Buy
+6,702
New +$2.2M 0.13% 148

Other funds holding BIIB

Siemens Fonds Invest's BIIB Position: Q2 2026 in Review

Siemens Fonds Invest held its Biogen (BIIB) position steady in Q2 2026 at 3,633 shares worth $785K. The position accounts for 0.04% of the portfolio, ranked #290.

Siemens Fonds Invest first reported a position in BIIB in Q3 2021 and has held it in 20 quarters since. The position peaked at $1.91M in Q2 2023. 1,038 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Siemens Fonds Invest held 3,633 shares of Biogen worth $785K as of Q2 2026.
  • Siemens Fonds Invest left its Biogen share count unchanged in Q2 2026.
  • Biogen made up 0.04% of Siemens Fonds Invest's portfolio in Q2 2026, its #290 holding.
  • Siemens Fonds Invest first reported a position in Biogen in Q3 2021 and has held it in 20 quarters since.
  • Siemens Fonds Invest's Biogen position peaked at $1.91M in Q2 2023.
  • 1,038 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Siemens Fonds Invest's 13F filing for Q2 2026, filed 14 Aug 2026.